Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1969 Mar;16(3):387-97.

Formation of rabbit reaginic antibodies to protein and hapten-protein conjugates

Formation of rabbit reaginic antibodies to protein and hapten-protein conjugates

O Strannegård et al. Immunology. 1969 Mar.

Abstract

The capacities of BSA and DNP—protein conjugates to evoke reagin formation in rabbits were compared. Reagins to DNP generally appeared earlier and disappeared more rapidly from the circulation than did anti-BSA reagins. Initial formation of reagins proceeded with a logarithmic phase indicating a doubling time of 7–8 hours. Booster antigen injections resulted in some cases in a reagin response after a shorter latent phase than that observed after primary immunization. A secondary reagin response was more readily evoked in rabbits with low titres of agglutinating antibodies than in those with high titres. Anti-DNP reagins were demonstrable in a higher percentage of the injected rabbits than were anti-BSA reagins. The two types of reagins were equally sensitive to heat and 2-mercaptoethanol. A positive correlation between serum levels of anti-DNP but not anti-BSA reagins and agglutinating antibodies was demonstrated. Some evidence that a low antigen dose was more efficient than a high dose in evoking reagin formation was obtained. Treatment of rabbits with 6-mercaptopurine during the 1st week following antigen injection resulted in an increased latent phase and an enhancement of the production of anti-BSA reagins and some suppression of the formation of anti-DNP reagins.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1966 Jan 1;123(1):173-90 - PubMed
    1. J Exp Med. 1966 May 1;123(5):935-50 - PubMed
    1. J Immunol. 1966 Jul;97(1):75-85 - PubMed
    1. J Exp Med. 1966 Sep 1;124(3):363-78 - PubMed
    1. Prog Allergy. 1967;10:37-83 - PubMed

LinkOut - more resources